Imperial College London
Portrait Picture

ProfessorIainMcNeish

Faculty of Medicine, Department of Surgery & Cancer

Chair in Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2185i.mcneish Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

G036Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Vergote:2022:10.1016/S1470-2045(22)00139-5,
author = {Vergote, I and Gonzalez-Martin, A and Lorusso, D and Gourley, C and Mirza, MR and Kurtz, J-E and Okamoto, A and Moore, K and Kridelka, F and McNeish, I and Reuss, A and Votan, B and du, Bois A and Mahner, S and Ray-Coquard, I and Kohn, EC and Berek, JS and Tan, DSP and Colombo, N and Zang, R and Concin, N and O'Donnell, D and Rauh-Hain, A and Herrington, CS and Marth, C and Poveda, A and Fujiwara, K and Stuart, GCE and Oza, AM and Bookman, MA and participants, of the 6th Gynecologic Cancer InterGroup GCIG Ovarian Cancer Consensus Conference on Clinical Research},
doi = {10.1016/S1470-2045(22)00139-5},
journal = {The Lancet Oncology},
pages = {e374--e384},
title = {Sixth ovarian cancer consensus conference on clinical research of the gynecologic cancer InterGroup},
url = {http://dx.doi.org/10.1016/S1470-2045(22)00139-5},
volume = {23},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research (OCCC6) was held virtually in October 2021 following published consensus guidelines. All 33 GCIG member groups participated in the development, refinement, and adoption of 20 statements within 4 topic groups on clinical research including first line treatment, recurrent disease, disease subgroups and future trials. Unanimous consensus was obtained for 14 of 20 statements, with >90% concordance in the remaining 6 statements. The high acceptance rate following active deliberation amongst the GCIG groups confirmed that a consensus process could be applied in a virtual setting.  Together with detailed categorisation of unmet needs, these consensus statements will promote harmonisation of international clinical research in ovarian cancer.
AU  - Vergote,I
AU  - Gonzalez-Martin,A
AU  - Lorusso,D
AU  - Gourley,C
AU  - Mirza,MR
AU  - Kurtz,J-E
AU  - Okamoto,A
AU  - Moore,K
AU  - Kridelka,F
AU  - McNeish,I
AU  - Reuss,A
AU  - Votan,B
AU  - du,Bois A
AU  - Mahner,S
AU  - Ray-Coquard,I
AU  - Kohn,EC
AU  - Berek,JS
AU  - Tan,DSP
AU  - Colombo,N
AU  - Zang,R
AU  - Concin,N
AU  - O'Donnell,D
AU  - Rauh-Hain,A
AU  - Herrington,CS
AU  - Marth,C
AU  - Poveda,A
AU  - Fujiwara,K
AU  - Stuart,GCE
AU  - Oza,AM
AU  - Bookman,MA
AU  - participants,of the 6th Gynecologic Cancer InterGroup GCIG Ovarian Cancer Consensus Conference on Clinical Research
DO  - 10.1016/S1470-2045(22)00139-5
EP  - 384
PY  - 2022///
SN  - 1213-9432
SP  - 374
TI  - Sixth ovarian cancer consensus conference on clinical research of the gynecologic cancer InterGroup
T2  - The Lancet Oncology
UR  - http://dx.doi.org/10.1016/S1470-2045(22)00139-5
UR  - http://hdl.handle.net/10044/1/95321
VL  - 23
ER  -
Download